Join Our Effort to Develop Drugs That Target the Pathways of Human Disease
Regulus is the leading company in the field of microRNA therapeutics. Regulus is advancing microRNA therapeutics across several key areas, including oncology, fibrosis, hepatitis C (HCV) infection and metabolic diseases.
Regulus is located in La Jolla, California, and is led by a seasoned executive team with proven expertise in corporate management, business operations, scientific and drug discovery and drug development.
Regulus provides a competitive benefits package that includes a choice of health, vision, and dental insurance, life insurance, flexible spending accounts, 401K plan, vacation, and stock options.
Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad … more